These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 20921486)

  • 1. Comparative effectiveness research in mental health: an advocate's perspective.
    Shern DL; Beronio KK; Minniear CC; Steverman SM
    Health Aff (Millwood); 2010 Oct; 29(10):1857-62. PubMed ID: 20921486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A patient advocate's perspective on patient-centered comparative effectiveness research.
    Coelho T
    Health Aff (Millwood); 2010 Oct; 29(10):1885-90. PubMed ID: 20921490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving mental health treatments through comparative effectiveness research.
    Wang PS; Ulbricht CM; Schoenbaum M
    Health Aff (Millwood); 2009; 28(3):783-91. PubMed ID: 19414887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effectiveness research.
    Katz MC
    Conn Med; 2011 May; 75(5):309-11. PubMed ID: 21678848
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis in severe mental illness: outcome measures selection.
    Stant AD; Buskens E; Jenner JA; Wiersma D; TenVergert EM
    J Ment Health Policy Econ; 2007 Jun; 10(2):101-8. PubMed ID: 17603150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Marginal medicine': targeting comparative effectiveness research to reduce waste.
    Hoffman A; Pearson SD
    Health Aff (Millwood); 2009; 28(4):w710-8. PubMed ID: 19556249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The policies and politics of creating a comparative clinical effectiveness research center.
    Wilensky GR
    Health Aff (Millwood); 2009; 28(4):w719-29. PubMed ID: 19556248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advocacy for children's mental health: a personal journey.
    Knitzer J
    J Clin Child Adolesc Psychol; 2005 Dec; 34(4):612-8. PubMed ID: 16232058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of integrated care for elderly depressed patients in the PRISM-E study.
    Wiley-Exley E; Domino ME; Maxwell J; Levkoff SE
    J Ment Health Policy Econ; 2009 Dec; 12(4):205-13. PubMed ID: 20195008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What outcomes should US policy makers compare in comparative effectiveness research?
    Bridges JF; Buttorff C
    Expert Rev Pharmacoecon Outcomes Res; 2010 Jun; 10(3):217-20. PubMed ID: 20545584
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mental health policy development in Africa.
    Gureje O; Alem A
    Bull World Health Organ; 2000; 78(4):475-82. PubMed ID: 10885166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maximizing efficiency and impact in effectiveness and services research.
    Chambers DA; Wang PS; Insel TR
    Gen Hosp Psychiatry; 2010; 32(5):453-5. PubMed ID: 20851264
    [No Abstract]   [Full Text] [Related]  

  • 14. Young rural people at risk for schizophrenia: time for mental health services to translate research evidence into best practice of care.
    Stain HJ; Clark S; O'Donnell M; Schall U
    Aust N Z J Psychiatry; 2010 Oct; 44(10):872-82. PubMed ID: 20932200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translating comparative effectiveness into practice: the case of diabetes medications.
    Shah ND; Mullan RJ; Breslin M; Yawn BP; Ting HH; Montori VM
    Med Care; 2010 Jun; 48(6 Suppl):S153-8. PubMed ID: 20473211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementing effectiveness research and improving care for schizophrenia in real-world settings.
    Buckley PF; Miller A; Chiles JA; Sajatovic M
    Am J Manag Care; 1999 Jun; 5 Spec No():SP47-56. PubMed ID: 10538860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advocacy for mental health: roles for consumer and family organizations and governments.
    Funk M; Minoletti A; Drew N; Taylor J; Saraceno B
    Health Promot Int; 2006 Mar; 21(1):70-5. PubMed ID: 16344283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A collaborative approach to targeted treatment development for schizophrenia: a qualitative evaluation of the NIMH-MATRICS project.
    Bromley E
    Schizophr Bull; 2005 Oct; 31(4):954-61. PubMed ID: 16166607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing comparative effectiveness research on prescription drugs: lessons from the clinical trial literature.
    Chokshi DA; Avorn J; Kesselheim AS
    Health Aff (Millwood); 2010 Oct; 29(10):1842-8. PubMed ID: 20921484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.